哈克特服務 HCKT 深 滬
已收盤 02-06 16:00:00 美东时间
16.17
+0.140
+0.87%
華盛通- 最 高16.23
- 今 開16.07
- 成交量 22.51万股
- 最 低 15.885
- 昨 收 16.03
- 總市值 4.06亿
- 52周最高 33.5434
- 市盈率 靜 15.33
- 換手率 0.90%
- 52周最低 15.885
- 委 比 -94.22%
- 總股本 2509.91万
- 歷史最高 33.5434
- 量 比 0.86
- 振 幅 2.15%
- 歷史最低 -0.895
- 每 手 1
- 風險率 3.90%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Hackett Completes $40.6M Dutch Auction Tender Offer, Repurchasing 2.03M Shares At $20 Each Or 7.5% Of Outstanding Stock
The Hackett Group, Inc. (NASDAQ:HCKT) ("Hackett" or the "Company"), a leading generative artificial intelligence ("Gen AI") consultancy and executive advisory firm, today announced the final results of its modified
2025-12-09 05:37
The Hackett Group shares are trading higher following Q3 earnings and a Dutch Tender Offer announcement.
The Hackett Group shares are trading higher following Q3 earnings and a Dutch T...
2025-11-05 05:13
The Hackett Group Q3 Adj. EPS $0.37, Inline, Sales $73.111M Miss $75.045M Estimate
The Hackett Group (NASDAQ:HCKT) reported quarterly earnings of $0.37 per share which met the analyst consensus estimate. This is a 13.95 percent decrease over earnings of $0.43 per share from the same period last year.
2025-11-05 05:09
P/E Ratio Insights for Hackett Group
In the current session, Hackett Group Inc. (NASDAQ:HCKT) is trading at $18.50, ...
2025-10-29 02:01
美股大行评级 | 买入！Fermi、Neptune获多家大行首予评级；伯克希尔哈撒韦罕见地获得“卖出”评级；摩根大通上调苹果目标价升至290美元
今日重点评级关注：Guggenheim：上调Neumora Therapeutics评级至"买入"，目标价14美元；韦德布什：上调Fate Therapeutics评级至"跑赢大市"，目标价从5美元升至7美元
2025-10-28 10:08
Barrington Research Maintains Outperform on Hackett Group, Maintains $27 Price Target
Barrington Research analyst Vincent Colicchio maintains Hackett Group (NASDAQ:HCKT) with a Outperform and maintains $27 price target.
2025-10-27 19:48
Barrington Research Maintains Outperform on Hackett Group, Maintains $27 Price Target
Barrington Research analyst Vincent Colicchio maintains Hackett Group (NASDAQ:HCKT) with a Outperform and maintains $27 price target.
2025-09-04 19:38
美股大行评级 | Rivian遭多家大行下调目标价；巴克莱上调超微公司目标价从130美元升至200美元
今日重点评级关注：韦德布什：维持Gossamer Bio"跑赢大市"评级，目标价从4美元升至5美元；HC Wainwright & Co.：维持EyePoint Pharmaceuticals"买入"评级，目标价从22美元升至23美元
2025-08-07 09:46
Hackett Group shares are trading lower after the company issued Q3 guidance below estimates.
Hackett Group shares are trading lower after the company issued Q3 guidance bel...
2025-08-06 20:29
Hackett Group Sees Q3 Adj EPS $0.36-$0.38 vs $0.43 Est; Sees Sales $73.000M-$76.000M vs $81.74M Est
Hackett Group (NASDAQ:HCKT) is looking for Q3 Adj EPS of $0.36-$0.38 vs $0.43 analyst estimate. sees sales of $73.000 million-$76.000 million vs $81.74 million analyst estimate.
2025-08-06 04:21
